Indian drugmakers need more FDA approvals to maintain growth

02/16/2009 | Business Standard (India)

Indian pharmaceutical companies including Dr. Reddy's Laboratories and Sun Pharma would require at least 12 to 14 FDA approvals to achieve their 20% sales growth target in the U.S., according to a Credit Suisse report. Ranbaxy Laboratories, which is under investigation for manufacturing violations, needs 20 more approvals to hit the target this year, the report said.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY